GLP-1 analogs decrease both fasting and postprandial blood glucose levels without causing hypoglycemia and while enabling modest weight loss, a significant achievement for many patients with type 2 diabetes
18 DPP-4 inhibitors, as mentioned above, can be used safely in patients with renal impairment
While results vary, our evidence-based programs are designed for significant and sustainable weight loss
Reviews typically cant control for confounders (diet changes, exercise, stimulant intake, sleep, stress, or other supplements), and negative experiences are often underreported
The United Kingdom Prospective Diabetes Study (UKPDS) demonstrated that metformin reduced diabetes-related complications, including kidney disease, in overweight patients (106)
This setup creates a stable, cool environment without the risk of freezing